Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lupus Erythematosus, Systemic × High-Intensity Interval Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 15 Polycystic Ovary Syndrome 7 Prostatic Neoplasms 5 Neoplasms 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Lung Neoplasms 2 Insulin Resistance 2 Fatigue 2 Cardiotoxicity 2 Rectal Neoplasms 1 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Inflammation 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Diabetes Mellitus, Type 1 1 Chemotherapy-Related Cognitive Impairment 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Cachexia 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1 Anxiety Disorders 1

Interventions

High-Intensity Interval Training 1 Exercise 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed

Lupus Erythematosus, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡